Biological Capabilities

With a strong foundation in chemistry, we at Genosynth, in collaboration with our partners, offer a thorough characterization of the biological activity and pharmacological properties of small molecules. This is a vital step in drug discovery and development, and we are dedicated to delivering top-quality results.

Whether you provide the molecules or need them synthesized in our laboratory, we are prepared to meet your needs. Our advanced laboratory facilities are manned by a team of experienced scientists capable of synthesizing a broad range of molecules.

Our services extend beyond just characterization and synthesis of small molecules. We offer a suite of complementary services, providing a comprehensive solution for your drug discovery and development needs. From the initial concept to the final product, we provide expert guidance and support to ensure your project’s success.

At Genosynth, we are not just a service provider. We are your partner in discovery and development, committed to helping you drive the future of healthcare forward.

In the past we were involved in dozens of research projects in CNS, antivirals, oncology, and autoimmune disorders were accomplished, bringing compounds from primary HTS to clinics.

  • Primary enzyme and cell-based assays: These tests allow us to gauge the biological activity of small molecules, providing crucial insights into their potential therapeutic effects.
  • In vitro or in vivo models (cancer, autoimmune, etc): We utilize both in vitro (outside the body) and in vivo (within a living organism) models to study the effects of molecules on various diseases, including cancer and autoimmune disorders.
  • ADME studies: Absorption, Distribution, Metabolism, and Excretion (ADME) studies are conducted to understand how a molecule behaves within a biological system, which is essential for the creation of new therapeutic strategies.
  • Medicinal chemistry: Our team of experts applies the principles of chemistry and biology to the development of new therapeutic agents, optimizing their effectiveness and safety.
  • Computational and AI-driven drug design: We harness the power of artificial intelligence and computational modeling to expedite the process of therapeutic discovery. This involves predicting how molecules will interact with their targets and refining their structures for maximum efficacy.